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1 受体（Insulin-like Growth Factor Receptor-1 receptor，IGF-1R）通路与缺氧 HepG2
肝癌细胞 VEGF 的表达存在正相关性，而且姜黄素可能通过 IGF-1R 通路抑制缺
氧HepG2肝癌细胞VEGF的表达。因此，本研究通过构建 IGF-1R基因敲除HepG2
细胞模型及诱导其缺氧体外模型，来明确姜黄素是否通过 IGF-1R 通路抑制缺氧




































































Hepatocellular carcinoma(HCC) is one of the most common malignant tumor in the 
world, which is highly malignant and rich in blood supply, grew rapidly and conceal 
onset. As a solid tumor with lots of blood vessels，the main characteristic of HCC is 
the uncontrolled cancer cell proliferation, which brings about a hypoxia 
microenvironment in the tumor, thus promotes the angiogenesis. 
Curcumin (diferuloylmethane), extracted from the rhizome of the plant perennial 
herb Curcuma longa, is a liposoluble polyphenol pigment. Curcumin has a widespread 
pharmacological action, including antioxidant, anti-inflammation, anticoagulation, fat 
loss, anti-atherosclerosis, anti-neoplasm, anti-angiogenesis, liver protection, 
anti-aging, etc. Having advantages of extensive anti-neoplasm spectrum, 
little side-effect and low price makes curcumin the hot issue in recent research. 
However, the mechanism of the anti-angiogenesis for curcumin is 
clarified  incompletely which is worth studying.  
The cell signaling pathway plays an important role in the occur and development 
progress of neoplasm. The research, done by our laboratory group,  has shown 
a positive correlation between the IGF-1R pathway and expression of VEGF in 
hypoxia-induced HepG2 cells. The purpose of the present study is to confirm whether 
the curcumin inhibited VEGF expression via IGF-1R pathway in hypoxia-induced 
HepG2 cells.  
We constructed IGF-1R knockout HepG2 cell based on CRISPR/Cas9 technology 
simply and efficiently。MTT assay was used to observe the influence of IGF-1R 
knockout on HepG2 cells vitality, and curcumin on IGF-1R knockout HepG2 cells 
and HepG2 cells vitality. The results indicated, compared with HepG2 cells, IGF-1R 
knockout HepG2 cells proliferation was inhibited. And curcumin  has 
a greater inhibitive effect on IGF-1R knockout HepG2 cells than HepG2 cells.   















α, VEGF expressions induced by hypoxia. We set up the hypoxia model using the 
cobalt chloride (CoCl2), and MTT assay was used to observe the influence of hypoxia 
on IGF-1R knockout HepG2 cells vitality. Western-blot assay was used to detect the 
IGF-1R, HIF-1α, VEGF protein expressions. The results showed that CoCl2 induced 
IGF-1R knockout HepG2 cells anoxic in a dose- and time-dependent manner , the 
cytotoxicity increased along with the time of culture 
and  the increase of doses of CoCl2. The HIF-1α protein had significant positive 
correlations with the VEGF protein expressions in a dose- and time-dependent manner, 
which indicated that hypoxia could induced the HIF-1 α and VEGF protein 
expressions via other pathways. 
To make sure whether curcumin inhibited the VEGF expression via IGF-1R 
pathway in hypoxia-induced IGF-1R knockout HepG2 cells. The influence of 
curcumin on cell survival in hypoxia-induced IGF-1R knockout HepG2 cells was 
accomplished by MTT assay. Western-blot was used to detect the IGF-1R, P-Akt, 
P-Erk1/2, HIF-1α  and VEGF protein expressions. The results suggested that 
curcumin inhibited hypoxia-induced IGF-1R knockout HepG2 cells vitality in 
a dose- and time-dependent manner. Curcumin can inhibit the HIF-1αand VEGF 
protein expression in hypoxia-induced HepG2 cells via IGF-1R pathway and other 
pathways. 
In summary, our research proved that curcumin can can inhibit VEGF expression in 
hypoxia-induced HepG2 cells not only via IGF-1R pathway, but also other pathways, 
which need further study. The results would improve the treatment and prevention of 
curcumin on liver cancer. 
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Hepatocellular carcinoma  

































transcatheter arterial and portal vein 
embolization 
basic fibroblast growth factor  
platelet-derived growth factor 
transforming growth factor-β 
interleukin-8 
placental-like growth factor  
IκB kinase  
Curcumin 
Interferon-γ 






































英文缩写 英文全称 中文全称 
Akt 
MAPK 











protein kinase B  
mitogen-activated protein kinases 
extracellular regulated protein kinases 
double stranded break  
non-homologous end joining 
homology directed repair 
clustered regularly interspaced short 
palindromic repeats 
Zinc-finger endonuclease 
transcription activator-like effector 
nuclease 
single-guide RNA 
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[1, 2]。据统计，在所有的恶性肿瘤中，HCC 的发病率排第 5 位，并且在肿瘤相关














治疗中晚期 HCC 非手术治疗最重要的方法。TACE 可以明显降低肿瘤负荷，延
长患者生存期，提高不能切除的 HCC 患者生活质量，大幅度改善预后。但是，
TACE 也有其缺点和局限性。单纯 TACE 治疗后 HCC 既因缺血缺氧和化疗药物
的细胞毒作用引起 HCC 细胞坏死,但仅选择性阻断肝动脉，HCC 仍然可以通过
门静脉获得部分血供, 也可通过肝周韧带或与周围组织粘连而获得侧支血供，或
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